Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Chest MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Expanding the lung donor pool and improving outcomes.JAMA Surg. 2019; 154: 1151
- Extended donor criteria for lung transplantation-a clinical reality.Eur J Cardiothorac Surg. 2005; 27: 757-761
- Expanding controlled donation after the- circulatory determination of death: statement from an international collaborative.Intensive Care Med. 2021; 47: 265-281
- ISHLT position paper on thoracic organ transplantation in controlled donation after circulatory determination of death (cDCD).J Heart Lung Transplant. 2022; 41: 671-677
- Long-term outcomes of lung transplant with ex vivo lung perfusion.JAMA Surg. 2019; 154: 1143-1150
- Operative techniques in thoracic and cardiovascular surgery.. 2004; 19: 433-442
- Lung Transplantation after Ex Vivo Lung Perfusion versus static cold storage: an institutional cost analysis.Am J Transpl. 2021; 22 (online PMID: 34379885): 552-564
- Ex vivo lung perfusion in lung transplantation.Gen Thorac Cardiovasc Surg. 2021; 69: 625-630
- Extracorporeal lung perfusion.Curr Opin Organ Transpl. 2011; 16: 469-475
- Strategies for safe donor expansion: donor management, donations after cardiac death, ex-vivo lung perfusion.Curr Opin Organ Transpl. 2013; 18: 513-517
- One-year immunologic outcomes of lung transplantation utilizing hepatitis C-viremic donors.Clinical Transpl. 2022; 36: e14749
- Trends in donation after circulatory death in lung transplanation in the United States: impack of era.Transpl Int. 2022; 35: 10172
- Cost evaluation of a donation after cardiac death program: how cost per organ compares to other donor types.J Am Coll Surg. 2018; 226: 909-916
- Influence of lung donor agonal and warm ischemic times on early mortality: analyses from the ISHLT DCD Lung Transplant Registry.J Heart Lung Transpl. 2019; 38: 26-34
- Impact of donor time to cardiac arrest in lung donation after circulatory death.J Thorac Cardiovasc Surg. 2021; 161: 1546-1555
- Lung transplantation using controlled donation after circulatory death donors: trials and tribulations.J Heart Lung Transpl. 2016; 35: 146-147
- International society for heart and lung transplantation donation after circulatory death Registry report.J Heart Lung Transpl. 2015; 34: 1278-1282
- Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry.J Heart Lung Transpl. 2019; 38: 1235-1245
- New classification of donation after circulatory death donors definitions and terminology.Transpl Int. 2016; 29: 749-759
- Lung Transplantation from donation after cardiocirculatory death: a systematic review and meta-analysis.J Heart Lung Transpl. 2015; 34: 675-684
- Lung transplantation with controlled donation after circulatory death donors.Ann Thorac Cardiovasc Surg. 2018; 24: 296-302
- Lung Transplantation with donation after cardiac death donors: long-term follow-up in a single center.J Thorac Cardiovasc Surg. 2010; 139: 1306-1315
- Assessment of lungs for transplant recovered from uncontrolled donation after circulatory determination of death donors.Ann Am Thorac Soc. 2017; 14: S251
- Initial lung transplantation experience with uncontrolled donation after cardiac death in North America.Am J Transpl. 2020; 20: 1574-1581
- Results of clinical lung transplant from uncontrolled non-heart-beating donors.J Heart Lung Transpl. 2007; 26: 529-534
- Excellent long-term outcome with lungs obtained from uncontrolled donation after circulatory death.Am J Transpl. 2019; 19: 1195-1201
- Outcomes of lung transplantation from organ donation after medical assistance in dying: first North American Experience.Am J Transpl. 2022; 22: 1637-1645
- Lung transplant outcome following donation after euthanasia.J Heart Lung Transpl. 2022; 41: 745-754
- Expanding the lung donor pool: advancements and emerging pathways.Curr Opin Organ Transpl. 2015; 20: 498-505
- An audit of lung donor pool: optimal current donation strategies and the potential of novel time-extended donation after circulatory death donation.Heart Lung Circ. 2021; S1443-9506: 00573-00574
- Primary graft dysfunction.Semin Respir Crit Care Med. 2013; 34: 305-319
- Ex Vivo Lung Perfusion: a key tool for translational science in the lungs.Chest. 2017; 151: 1220-1228
- Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation.Transpl Int. 2014; 27: 553-561
- Donor management and lung preservation for lung transplantation.Lancet Repir Med. 2013; 1: 318-328
- Normothermic ex vivo lung perfusion in clinical lung transplantation.N Engl J Med. 2011; 364: 1431-1440
- The NOVEL lung trial one-year outcomes.JHLT. 2014; 33: S71-S72
- Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial.Lancet. 2019; 7: P975-P984
- Centralized Organ Recovery and Reconditioning Centers.Thorac Surg Clin. 2022; 32: 167-174
- Outcomes after transplantation of lungs preserved for more than 12 hrs.A Retrospective Study Lancet Respir Med. 2017; 5: 119-124
- Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion.J Heart Lung Transpl. 2016; 35: 130-136
- Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: results from a multicentric study.J Heart Lung Transpl. 2020; 39: 954-961
- Ex vivo perfusion treatment of infection in human donor lungs.Am J Transpl. 2016; 16: 1229-1237
- The effect of ex vivo lung perfusion on microbial load in human donor lungs.J Heart Lung Transpl. 2014; 33: 910-916
- Successful lung transplantation after donor lung reconditioning with urokinase in ex vivo lung perfusion system.Ann Thorac Surg. 2014; 98: 1837-1838
- Ex vivo lung perfusion as a human platform for preclinical small molecule testing.JCI Insight. 2018; 3: e95515
- Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion.Nat Commun. 2019; 10: 481
- Safety and Efficacy of Ex Vivo Donor Lung Adenoviral IL-10 gene therapy in a large animal lung transplant survival model.Hum Gene Ther. 2017; 28: 757-765
- Static lung storage at 10C maintains mitochondrial health and preserves donor organ function.Sci Transl Med. 2021; 13: eabf7601
- Safety of continuous 12-hour delivery of antimicrobial doses of inhaled nitric oxide during ex vivo lung perfusion.J Thorac Cardiovasc Surg. 2022; 163: 841-849
- Hydrogen gas inhalation during ex vivo lung perfusion of donor lungs recovered after cardiac death.J Heart Lung Transpl. 2018; 37: 1271-1278
- Utlizations of hepatitis C virus-infected organ donors in cardiothoracic transplantation: an ISHLT expert consensus statement.J Heart Lung Transpl. 2020; 39: 418-432
- Heart and lung transplants from HCV-infected donors to uninfected recipients.N Engl J Med. 2019; 380: 1606-1617
- Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-cetre, open-label study.Lancet Gastroenterol Hepatol. 2020; 5: 649-657
- Outomes of lung transplantation from hepatitis C viremic donors.Ann Thorac Surg. 2022; 113: 1598-1607
Article info
Identification
Copyright
© 2022 Published by Elsevier Inc.
